
- 360 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
eBook - ePub
PARP as a Therapeutic Target
About this book
Recent research in cell death mechanisms has rekindled interest in PARP's (Poly (ADP-Ribose) Polymerase) intriguing role in necrosis and apoptosis. While the details of how PARP1 functions are still being elucidated, it has tremendous potential as a promising drug target. PARP inhibitors' dual actions of preventing cell death and abating inflammati
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access PARP as a Therapeutic Target by Jei Zhang in PDF and/or ePUB format, as well as other popular books in Medicine & Cell Biology. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Cover
- Half Title
- Title Page
- Title Page
- Copyright Page
- Dedication
- Foreword
- Preface
- Contributors
- Table of Contents
- Chapter 1 Nervous System Functions of Poly(ADP-Ribose) Polymerase-1
- Chapter 2 Role of Poly(ADP-Ribose) Polymerase-1 in Neurologic Disorders
- Chapter 3 Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of
- Chapter 4 Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and Radiosensitivity: A Genetic Rescue Study
- Chapter 5 PARP Inhibitors as Neuroprotective Agents for Brain Injury
- Chapter 6 PARP Inhibitors and Cardioprotection
- Chapter 7 Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor
- Chapter 8 Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure
- Chapter 9 Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation
- Chapter 10 Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target
- Chapter 11 Chemoprotective Effect of a Novel PARP Inhibitor
- Chapter 12 Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases
- Chapter 13 Protecting Effect of PARP Inhibition on Ultraviolet Light–Induced Skin Damage
- Chapter 14 Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction
- Chapter 15 Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities
- Index